Holen Sie sich die Stockscreener-App
2.62
3.68%
-0.10
Alterity Therapeutics Ltd Adr Aktie (ATHE) Neueste Nachrichten
Immutep Limited (IMMP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alterity Therapeutics (ATHE) ADR Edges Up 1.43% to $3.91, Holding Above $3.71 SupportAdvance Decline Line - https://www.dars.gov.et/
Alterity Therapeutics at Cantor healthcare conference: phase iii path sharpens By Investing.com - Investing.com South Africa
Alterity Therapeutics at Cantor healthcare conference: phase iii path sharpens - Investing.com
ALTERITY THERAPEUTICS LTD (NASDAQ: ATHE) Director Acquires 47,620 Shares at $0.50 Each - Kalkine Media
Immuron LimitedADR (IMRN) Peer Comparison – Compare with Others - Value Research
Alterity Therapeutics Director David Stamler's Listed Options Expire on 31 August 2026 - Kalkine
Alterity Therapeutics Reports A$17.6M in R&D Expenses for Fiscal Year Ending June 30, 2026 - Kalkine Media
Alterity Therapeutics (ATHE) Holds Steady at $4.51 as Shares Consolidate Within a Tight Trading RangeATR Trailing Stop - careplusvn.com
Kazia Therapeutics LimitedADR Peer Comparison – Compare with Others - Value Research
Alterity (ATHE) Chart: Closes 4.94% Higher at $4.67; Technical View: the Near-Term Reference Band Stretches From $4.44 to $4.90 in the Latest SessionFibonacci Entry Signals - dars.gov.et
Alterity (ATHE) Chart: Closes 4.94% Higher at $4.67; Technical View: the Near-Term Reference Band Stretches From $4.44 to $4.90 in the Latest SessionDip Buy Trade - careplusvn.com
Alterity (ATHE): Advances 4.94% to $4.67 for the Current Session; Next Session: the Supplied Trading Band Runs From $4.44 to $4.90 in Latest TradingHigh Beta Stocks - dars.gov.et
Alterity (ATHE): Advances 4.94% to $4.67 for the Current Session; Next Session: the Supplied Trading Band Runs From $4.44 to $4.90 in Latest TradingNAAIM Leverage - dars.gov.et
Alterity Therapeutics (ATHE) Declines 4.6% to $4.57 as Shares Test Key SupportDelta Hedging - careplusvn.com
Alterity Therapeutics Limited (ASX:ATH) Share Price Falls 4.46% as Stock Trades Within Daily Range - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Makes U.S. Pivot With Nasdaq Uplisting and Headquarters Shift Plan - Kalkine
Alterity Therapeutics Secures Key US Patent for Lead Asset - Sahm
Alterity Therapeutics at Canaccord conference: phase III path in focus By Investing.com - Investing.com India
Alterity Therapeutics at Canaccord conference: phase III path in focus - Investing.com
Craig-Hallum initiates Alterity Therapeutics stock coverage with buy rating - Investing.com
Acrux Ltd (ASX:ACR) Share Price Update: Trading Snapshot for 11 August 2026 - Kalkine
Alterity Therapeutics (ATHE) Climbs 3.41% as Shares Advance Toward $4.94 ResistanceLow Beta Factor - dars.gov.et
Alterity Therapeutics (ATHE) Climbs 3.41% as Shares Advance Toward $4.94 ResistancePut Dominated - careplusvn.com
Alterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key SupportFibonacci Fan - vinanet.vn
Alterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key SupportSentiment Divergence - dars.gov.et
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update - Yahoo Finance
PRNAF SEC FilingsALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
ATHE News | ALTERITY THERAPEUTICS-ADR (NASDAQ:ATHE) - ChartMill
[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) | ATHE SEC FilingForm 6-K - Stock Titan
Jones Trading initiates Alterity Therapeutics stock with buy rating - Investing.com
Alteriry Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ATHE) - TradingView
Is Allarity Therapeutics, Inc. (ALLR) outperforming other medical stocks this year? - MSN
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alterity Therapeutics Advances Lead Drug Towards Pivotal Study For Rare Neuromuscular Disorder - Sahm
Insights: Alterity Therapeutics Ltd (ASX:ATHDA) - smallcaps.com.au
ATHEAlterity Therapeutics Ltd ADR Short Interest - Finviz
ATHEAlterity Therapeutics Ltd ADR Volatility & Greeks - Finviz
Weiss Ratings Stock Recommendations & Analyst Ratings 2026 - marketbeat.com
Alterity Therapeutics (NASDAQ: ATHE) sets vote on 50:1 consolidation and large option, incentive issuances - Stock Titan
[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) | ATHE SEC FilingForm 6-K - Stock Titan
Alterity Therapeutics appoints Ann Cunningham to board - Investing.com
Alterity Therapeutics appoints Ann Cunningham to board By Investing.com - Investing.com India
Nerves settle as oil drops - The Cairns Post
Nerves settle as oil drops - Geelong Advertiser
Nerves settle as oil drops - Daily Telegraph Sydney
Alterity Therapeutics Receives Positive FDA Feedback for ATH434 Phase 3 MSA Program - smallcaps.com.au
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
Ameritas Investment Partners Inc. Raises Stock Holdings in Kratos Defense & Security Solutions, Inc. $KTOS - Defense World
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):